Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ·Healthcare·Biotechnology
$83.89
+0.16%
Mkt Cap $8.88B
Analyst Ratings
Buy
4
Hold
6
Sell
0
Price Target (31 analysts)
$80.57
Range $55.00 – $85.00
Implied Upside
-4.0%
Consensus $80.57 vs current $83.89
NASDAQ·Healthcare·Biotechnology
$83.89
+0.16%
Mkt Cap $8.88B
Buy
4
Hold
6
Sell
0
Price Target (31 analysts)
$80.57
Range $55.00 – $85.00
-4.0%
Consensus $80.57 vs current $83.89